Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...

However, BitMine (BMNR) stock is still trading below $30 despite the large holdings. Ethereum’s path to $4,000 remains in focus, with technical indicators signaling bullishness and institutional ...

Precigen, Inc. ( PGEN) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 10:30 AM EST ...

Program Updates and Anticipated 2026 Milestones: TN-201 -- Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy (HCM) ...

DAVOS: Manpower Group sees the global staffing market stabilising after a difficult 2025 and says improving economic conditions could set up the industry for growth in 2026, even as employers and ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Microsoft’s investigation into RedVDS services and infrastructure uncovered a global network of disparate cybercriminals ...

Bitcoin started 2026 stuck near $88,000, extending weeks of sideways trading. While price action looks stagnant, on-chain data suggests the market may be quietly shifting beneath the surface. Three ...

A bite-sized show about big ideas. From the people who make Planet Money, The Indicator helps you make sense of what's happening in today's economy. It's a quick hit of insight into money, work, and ...

Bitcoin’s 31% drop ($126K to $87K) matches mid-cycle corrections: Falls within 25-40% range typical of bull market resets. Historical recovery timelines suggest 3-6 month consolidation. The current ...

Bitcoin ends 2025 in an odd place: structurally stronger, but tactically bruised. BTC-USD trades around 87,000 to 88,000 dollars, down about 6 percent for the year and roughly 30 percent below the ...

Stocks to buy for the short term: The Indian stock market ended the holiday-truncated week nominally higher amid subdued trading activity due to year-end adjustments. The Nifty 50 spent most of the ...